IP Library Granted Patent US 10,988,552
Granted Patent B2
US 10,988,552 · App. 16/928,545 · Granted Apr 27, 2021

Antibodies targeted to fungal cell wall polysaccharides

Inventors: Francis Michon (Bethesda, MD); Samuel J. Wohlstadter (Madison, VA); Frank Comer (Gaithersburg, MD); Kuishu Ren (Columbia, MD)
Assignee: Wellstat Vaccines, LLC
C08B37/003A61K39/0002A61K39/385A61K47/646A61K47/6415C07K16/14A61K2039/6031A61K2039/6037A61K2039/627
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,988,552
App. No.
16/928,545
Granted
Apr 27, 2021
Kind
B2
Abstract

A compound comprising one or more polysaccharide moieties each independently represented by the formula β(1→4)-[GlcNH—R] n -2,5-anhydromannose, wherein n is a positive integer from 3 to 500, and R is H or an acyl group, is described. The compound can be manufactured by (a) reacting chitosan with an acylating agent sufficient to partially N-acylate the chitosan, yielding a modified chitin/chitosan mixed polymer; and (b) reacting the modified chitin/chitosan mixed polymer with a deaminating agent to cleave the mixed polymer at the unacylated chitosan moieties. The compound can be used to immunize against fungal infection. Antibodies specific to the compound, and the use of such antibodies to protect against fungal infection are also described.

Claims (4)

1. An isolated and purified antibody specific to a compound, wherein the compound comprises:

one or more polysaccharide moieties, each independently represented by the formula β(1→4)-[GlcNH-R]n-2,5-anhydromannose, wherein n is a positive integer from 3 to 500, R is H or an acetyl group, and the one or more polysaccharide moieties are chitin/chitosan mixed polymers.

2. The antibody of claim 1 , wherein n is a positive integer from 3 to 100.

3. The antibody of claim 2 , wherein n is a positive integer from 6 to 50.

Continuity (6)
Division 16666503 · Oct 29, 2019
Division 16267430 · Feb 5, 2019
Continuation 15583396 · May 1, 2017
Continuation 14771923
Provisional Application 61777631 · Mar 12, 2013
Related Publication 20200339707A1 · Oct 29, 2020